McCann C C, Quera-Salva M A, Boudet J, Frisk M, Barthouil P, Borderies P, Meyer P
Service de Pharmacologie Clinique, Hôpital Necker Enfants-Malades, Paris, France.
Fundam Clin Pharmacol. 1993;7(6):305-10. doi: 10.1111/j.1472-8206.1993.tb00244.x.
A double-blind study comparing the effect of zolpidem 10 mg, and placebo, on sleep architecture, nocturnal ventilation, cardiovascular parameters (heart rate, systolic, diastolic and mean blood pressures) was carried out. Ten healthy middle-aged males took part in the study. No significant differences were found between zolpidem and placebo in relation to sleep architecture. Mean respiratory disturbance index (RDI) and SaO2 values (mean SaO2, time spent with SaO2 < 90%) were similar under both conditions. The diastolic and mean blood pressure readings taken from REM periods which occurred during the first third of the night were significantly higher with zolpidem. No changes in systolic blood pressure or heart rate were found with zolpidem in comparison to placebo.
开展了一项双盲研究,比较10毫克唑吡坦与安慰剂对睡眠结构、夜间通气、心血管参数(心率、收缩压、舒张压和平均血压)的影响。10名健康中年男性参与了该研究。唑吡坦与安慰剂在睡眠结构方面未发现显著差异。两种情况下的平均呼吸紊乱指数(RDI)和血氧饱和度(SaO2)值(平均SaO2、SaO2<90%的时长)相似。夜间前三分之一时间段快速眼动期的舒张压和平均血压读数,使用唑吡坦时显著更高。与安慰剂相比,使用唑吡坦时收缩压或心率未发现变化。